Literature DB >> 23649310

Meta-analysis of contemporary short- and long-term mortality rates in patients diagnosed with critical leg ischaemia.

K E Rollins1, D Jackson, P A Coughlin.   

Abstract

BACKGROUND: Critical leg ischaemia (CLI) has been associated with high mortality rates. There is a lack of contemporary data on both short- and long-term mortality rates in patients diagnosed with CLI.
METHODS: This was a systematic literature search for studies prospectively reporting mortality in patients diagnosed with CLI. Meta-analysis and meta-regression models were developed to determine overall mortality rates and specific patient-related factors that were associated with death.
RESULTS: A total of 50 studies were included in the analysis The estimated probability of all-cause mortality in patients with CLI was 3·7 per cent at 30 days, 17·5 per cent at 1 year, 35·1 per cent at 3 years and 46·2 per cent at 5 years. Men had a statistically significant survival benefit at 30 days and 3 years. The presence of ischaemic heart disease, tissue loss and older age resulted in a higher probability of death at 3 years.
CONCLUSION: Early mortality rates in patients diagnosed with CLI have improved slightly compared with previous historical data, but long-term mortality rates are still high.
© 2013 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23649310     DOI: 10.1002/bjs.9127

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial.

Authors:  Amish N Raval; Eric G Schmuck; Girma Tefera; Cathlyn Leitzke; Cassondra Vander Ark; Derek Hei; John M Centanni; Ranil de Silva; Jill Koch; Richard G Chappell; Peiman Hematti
Journal:  Cytotherapy       Date:  2014-09-18       Impact factor: 5.414

2.  Endovascular therapy is effective treatment for focal stenoses in failing infrapopliteal vein grafts.

Authors:  Gregory G Westin; Ehrin J Armstrong; Usman Javed; Christopher R Balwanz; Haseeb Saeed; William C Pevec; John R Laird; David L Dawson
Journal:  Ann Vasc Surg       Date:  2014-08-06       Impact factor: 1.466

Review 3.  Preventing Major Amputations in Patients with Critical Limb Ischemia.

Authors:  Eric W Rudofker; Shea E Hogan; Ehrin J Armstrong
Journal:  Curr Cardiol Rep       Date:  2018-07-10       Impact factor: 2.931

4.  A multivariate model for the meta-analysis of study level survival data at multiple times.

Authors:  Dan Jackson; Katie Rollins; Patrick Coughlin
Journal:  Res Synth Methods       Date:  2014-02-27       Impact factor: 5.273

5.  The Effect of Severe Femoropopliteal Arterial Calcification on the Treatment Outcome of Femoropopliteal Intervention in Patients with Ischemic Tissue Loss.

Authors:  Hyun Yong Lee; Ui Jun Park; Hyoung Tae Kim; Young-Nam Roh
Journal:  Vasc Specialist Int       Date:  2020-06-30

6.  Compared to Intermittant Claudication Critical Limb Ischemia Is Associated with Elevated Levels of Cytokines.

Authors:  Juho Jalkanen; Mikael Maksimow; Maija Hollmén; Sirpa Jalkanen; Harri Hakovirta
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

7.  MicroRNA let-7g possesses a therapeutic potential for peripheral artery disease.

Authors:  Po-Yuan Hsu; Edward Hsi; Tzu-Ming Wang; Ruey-Tay Lin; Yi-Chu Liao; Suh-Hang H Juo
Journal:  J Cell Mol Med       Date:  2016-10-03       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.